NCT02538198View on ClinicalTrials.gov

Lenalidomide Maintenance in Plasma Cell Myeloma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Plasma Cell Myeloma
Interventions
DRUG

Lenalidomide

Trial Locations (6)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11553

Memorial Sloan Kettering Nassau, Uniondale

11725

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack

Unknown

Memorial Sloan Kettering Cancer Center, Basking Ridge

07645

Memorial Sloan Kettering Bergen, Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER